Buscar resultados de ensayos clínicos

Patrocinado por

Diabetes Insipidus - 29 Studies Found

Estado Estudiar
Completed Nombre del estudio: Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
Condición:
  • Inappropriate ADH Syndrome
  • Hyponatremia

Fecha: 2005-12-12
Intervenciones: Drug: SR121463B
Completed Nombre del estudio: Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
Condición:
  • Syndrome of Inappropriate ADH (SIADH) Secretion
  • Hyponatremia

Fecha: 2002-03-29
Intervenciones: Drug: satavaptan (SR121463B)
Completed Nombre del estudio: V2 Receptor Effects on Fluid Regulation and Performance
Condición:
  • Electrolyte Imbalance
  • Hyponatremia
  • Hypernatremia
    • Fecha: 2014-03-10
    Intervenciones: Drug: V2R (Vasopressin 2 receptor) All ten subjects were used as their own controls in this double-blind
Completed Nombre del estudio: Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With Vasopressin
Condición:
  • Chronic Hepatitis C
  • Chronic Hepatitis B
  • Biopsy
  • Fecha: 2008-03-05
    Intervenciones: Procedure: Percutaneous liver biopsy Two passes of PLB from the right hepatic lobe by US guidance (Toshi
Completed Nombre del estudio: Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia (The GOLD-Study)
Condición: Primary Polydipsia
Fecha: 2016-03-30
Intervenciones:
  • Drug: Dulaglutide Treatment wi
Completed Nombre del estudio: Copeptin in Differentiation of Polyuria and Polydipsia
Condición:
  • Polyuria
  • Polydipsia

Fecha: 2010-01-25
Completed Nombre del estudio: Safety Study of Vasopressin V2 Receptor Antagonist on Patients With Severe Chronic Heart Failure (AQUAVIT).
Condición: Chronic Heart Failure
Fecha: 2002-03-29
Intervenciones: Drug: Vasopressin V2 Receptor Antagonist
Completed Nombre del estudio: DILIPO (DILutIonal HyPOnatremia)
Condición: Congestive Heart Failure
Fecha: 2006-01-09
Intervenciones: Drug: SR121463B
NOT_YET_RECRUITING Nombre del estudio: Effects of Intranasal Oxytocin in Patients With Central Diabetes Insipidus
Condición: Central Diabetes Insipidus
Fecha: 2025-11-04
Intervenciones: 4 IU intranasal oxytocin, 24 IU intranasal oxytocin or placebo
<<< Previous